Affichage 1 à 2 des 2 essais cliniques
ESSAI CLINIQUE
    No essai
    ClinicalTrials.gov ID
Investigateur(trice) principal(e)
Coordonnateur(rice)
(EN) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
    MK-3475-630/KEYNOTE-630
    NCT03833167
     Actif en recrutement
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN  

Peau Dr Nathaniel Bouganim

Paulina Garcia de Alba Graue
  514-934-1934 poste 34573
(EN) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
    MK-3475-630/KEYNOTE-630
    NCT03833167
     Actif en recrutement
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX  

Peau Dre Mai-Kim Gervais

Audrey Lamoureux
  514-252-3400 poste 6258